Tag: regulatory exclusivity
Regulatory exclusivity provides government-granted market protection for pharmaceuticals beyond patents. It ensures innovators have commercial time even if patents expire during development. Key types include 5-year NCE, 12-year biologics, and 7-year orphan drug exclusivity. Differences exist between U.S. and EU rules, with significant economic impacts on drug pricing and competition.
- Read More